The First Affiliated Hospital of Dali University, Dali, Yunnan Province, China.
Second Department of Production, Handan Central Hospital, Handan, Hebei Province, China.
Medicine (Baltimore). 2023 Nov 10;102(45):e35953. doi: 10.1097/MD.0000000000035953.
Cervical cancer (CC) is the fourth most common cancer in women worldwide. It develops through precancerous lesions (cervical intraepithelial neoplasia (CIN), graded from low-grade (CIN1) to high-grade (CIN2-3)). It is well established that precancerous and cancerous cervical lesions are caused by a persistent infection with high-risk types of the human papilloma virus (hrHPV). To have a deeper understanding of the pathogenesis of CIN and CC, we systematically analyzed the landscape of genomic alterations and HPV integration profiles in high-grade CIN2/3. We performed deep whole genome sequencing on exfoliated cervical cells and matched peripheral blood samples from a cohort of 51 Chinese patients (of whom 35 were HPV+) with high-grade CIN from 3 ethnic groups and constructed strict integrated workflow of genomic analysis. In addition, the HPV types and integration breakpoints in the exfoliated cervical cells from these patients were examined. Genomic analysis identified 6 significantly mutated genes (SMGs), including CDKN2A, PIK3CB, FAM20A, RABEP1, TMPRSS2 and SS18L1, in 51 CIN2/3 samples. As none of them had previously been identified as SMGs in the Cancer Genome Atlas cervical squamous cell carcinoma and endocervical adenocarcinoma (TCGA-CESC) cohort, future studies with larger sample size of CINs may be needed to validate our findings. Mutational signature analysis showed that mutational signatures of CINs were dramatically different from CCs, highlighting their different mutational processes and etiologies. Moreover, non-silent somatic mutations were detected in all of the CIN2/3 samples, and 88% of these mutations occurred in genes that also mutated in CCs of TCGA cohort. CIN2 samples had significantly less non-silent mutations than CIN3 samples (P = .0006). Gene ontology and pathway level analysis revealed that functions of mutated genes were significantly associated with tumorigenesis, thus these genes may be involved in the development and progression of CC. HPV integration breakpoints occurred in 28.6% of the CIN2/3 samples with HPV infection. Integrations of common high risk HPV types in CCs, including HPV16, 52, 58 and 68, also occurred in the CIN samples. Our results lay the groundwork for a deeper understanding of the molecular mechanisms underlying the pathogenesis of CC and pave the way for new tools for screening, diagnosis and treatment of cervical precancerous and cancerous lesions.
宫颈癌(CC)是全球女性中第四常见的癌症。它通过癌前病变(宫颈上皮内瘤变(CIN),分为低级别(CIN1)到高级别(CIN2-3))发展而来。已经确定,宫颈癌前病变和癌症是由高危型人乳头瘤病毒(hrHPV)持续感染引起的。为了更深入地了解 CIN 和 CC 的发病机制,我们系统地分析了来自 3 个种族的 51 名中国高级别 CIN2/3 患者的脱落宫颈细胞和配对外周血样本中基因组改变和 HPV 整合图谱。我们对 51 名 HPV+高级别 CIN 患者的脱落宫颈细胞和配对外周血样本进行了深度全基因组测序,并构建了严格的基因组分析综合工作流程。此外,还检测了这些患者脱落宫颈细胞中的 HPV 类型和整合断点。基因组分析在 51 个 CIN2/3 样本中鉴定出 6 个显著突变基因(SMGs),包括 CDKN2A、PIK3CB、FAM20A、RABEP1、TMPRSS2 和 SS18L1。由于它们在癌症基因组图谱宫颈鳞状细胞癌和子宫内膜腺癌(TCGA-CESC)队列中均未被鉴定为 SMGs,因此可能需要更大样本量的 CIN 研究来验证我们的发现。突变特征分析表明,CIN 的突变特征与 CC 显著不同,突出了它们不同的突变过程和病因。此外,所有 CIN2/3 样本中均检测到非沉默性体细胞突变,这些突变中有 88%发生在 TCGA 队列中 CC 也发生突变的基因中。CIN2 样本的非沉默性突变明显少于 CIN3 样本(P=0.0006)。基因本体论和途径水平分析表明,突变基因的功能与肿瘤发生显著相关,因此这些基因可能参与了 CC 的发生和发展。HPV 整合断点发生在 28.6%感染 HPV 的 CIN2/3 样本中。包括 HPV16、52、58 和 68 在内的常见高危 HPV 类型在 CIN 样本中的整合也发生了。我们的研究结果为深入了解 CC 发病机制的分子机制奠定了基础,并为宫颈癌前病变和癌症的筛查、诊断和治疗开辟了新的工具。